FDA approves Roche skin cancer drug
(Reuters) – U.S. health regulators on Monday approved Roche's pill to treat an advanced form of the most common form of skin cancer, known as basal cell carcinoma. The drug, Erivedge, which was co-developed by Curis Inc, was given a green ligh…
View full post on Yahoo! Health News
approves, Cancer, drug, Roche, Skin